No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up studyBrenda Hermsen, Matti A. Rookus, R.I. Olivier et al.|British Journal of Cancer|2007Cited by 153
Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre studyMarline G. Harmsen, Joanne A. de Hullu, M.A.D.W. de Jong et al.|BMC Cancer|2015Cited by 106
Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in <i>BRCA1/2</i> Pathogenic Variant CarriersMiranda P. Steenbeek, Joanne A. de Hullu, B.F.M. Slangen et al.|JAMA Oncology|2021Cited by 78
Peritoneal carcinomatosis after risk‐reducing surgery in <i>BRCA1/2</i> mutation carriersMarline G. Harmsen, Joanne A. de Hullu, Jurgen M.J. Piek et al.|Cancer|2018Cited by 40
Characteristics of Lynch syndrome associated ovarian cancerJorien M. Woolderink, Marian J.E. Mourits, Geertruida H. de Bock et al.|Gynecologic Oncology|2018Cited by 29